Anti-proliferative actions of T-type calcium channel inhibition in Thy1 nephritis

Andrea Cove-Smith1, Christopher J Mulgrew, Olena Rudyk

  • 1Department of Renal Medicine, King's College London, London, United Kingdom. andrea.cove-smith@kcl.ac.uk

Insights

TH1177, a T-type calcium channel (TCC) inhibitor, significantly reduced mesangial cell proliferation in vitro and in vivo. This suggests TCC inhibition may be a viable strategy for treating progressive glomerular diseases characterized by aberrant cell growth.

Area of Science:

  • Nephrology
  • Cell Biology
  • Pharmacology

Background:

  • Aberrant mesangial cell (MC) proliferation is a hallmark of progressive glomerular diseases.
  • T-type calcium channels (TCCs) are implicated in cellular proliferation.
  • TH1177 is a small molecule inhibitor of TCCs.

Purpose of the Study:

  • To investigate the effect of TH1177 on MC proliferation in vitro and in vivo.
  • To determine if TCC inhibition can ameliorate glomerular injury and MC overgrowth in a rat model of nephritis.

Main Methods:

  • In vitro studies utilized microculture tetrazolium assays and bromodeoxyuridine incorporation to assess rat MC proliferation.
  • In vivo studies involved treating rats with Thy1 nephritis with TH1177 or vehicle, followed by blinded assessment of glomerular injury, cell number, and markers of proliferation (Ki-67, pERK).
  • Quantitative real-time PCR was used to analyze TCC isoform expression in healthy and diseased kidney tissue.

Main Results:

  • TCC blockade significantly reduced rat MC proliferation in vitro, while L-type calcium channel inhibition had no effect.
  • TH1177 treatment in Thy1 nephritis model significantly reduced glomerular injury and glomerular cell number by 49%.
  • TH1177 administration also led to significant reductions in Ki-67 and pERK positive cells per glomerulus.

Conclusions:

  • TH1177 effectively inhibits mesangial cell proliferation both in vitro and in vivo.
  • These findings support the therapeutic potential of TCC inhibition for managing proliferative responses in glomerular diseases.
  • Targeting TCCs offers a promising strategy for future research and treatment of kidney injury.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...